Veterinary Parasiticides Market Revenue to Attain USD 20.67 Bn by 2033


18 Jul 2025

Share : linkedin twitter facebook

The global veterinary parasiticides market revenue surpass USD 13.63 billion in 2025 and is predicted to attain around USD 20.67 billion by 2033, growing at a CAGR of 5.34%. This growth of the market is attributed to the growing prevalence of parasitic infections in livestock as well as companion animals.

Veterinary Parasiticides Market Revenue Statistics

Market Overview

The worldwide veterinary parasiticides market is experiencing significant growth due to the increasing prevalence of parasites in animals. The rising adoption of pets, coupled with growing awareness of animal health and hygiene among owners, is driving demand for parasite control products. Simultaneously, the expansion of the market is fueled by higher meat and dairy consumption, positively influencing the use of parasiticides, as livestock producers require these products regularly to maintain optimal herd health and productivity.

Government initiatives promoting animal welfare, continuous advancements in veterinary medicine, and the rising introduction of novel, broad-spectrum parasiticides are stimulating market expansion. The increasing prevalence of zoonotic diseases in livestock animals further propels the growth of the market.

Segment Outlook

  • By product type, the endoparasiticides segment held the largest share of the market in 2024 due to its high usage to eliminate parasitic infections. The increasing need for more targeted, effective medicines is likely to bolster the segment further.
  • By animal type, the livestock animals segment led the market in 2024 due to the increased prevalence of infectious diseases in livestock animals. Since the demand for dairy and meat products is rising, there is a need to control internal and external parasites in production animals, such as cattle, poultry, pigs, sheep, and goats.
  • By mode of administration, the oral segment held the largest share of the market in 2024 since oral dosing of parasiticides is simple and easy for administration, ensuring higher compliance rates. The rising demand for long-term and convenient solutions for infection control boosts the adoption of oral formulations.
  • By distribution channel, the veterinary hospitals & clinics segment dominated the market in 2024, as they are the primary source of animal care. Veterinary hospitals and clinics ensure immediate availability of parasiticides, ensuring timely intervention.
  • By end-user, the farmers & livestock owners segment led the market in 2024. This is mainly due to the increased demand for effective parasite control solutions among them, driven by the increased concerns about animal productivity.

Regional Insights

North America sustains dominance in the veterinary parasiticides market by holding the largest share in 2024. The region’s market dominance stems from its high pet ownership, advanced veterinary healthcare systems, and greater awareness among pet owners about preventative care. A supportive regulatory environment and increased consumption of animal proteins further bolstered the market.

Meanwhile, Asia Pacific is emerging as the fastest-growing market. This is mainly due to the rising livestock production, along with the expansion of animal husbandry. There is a high prevalence of infectious diseases among animals, boosting the demand for parasiticides. Moreover, rising awareness of animal health and increasing access to veterinary care are likely to contribute to market expansion.

Veterinary Parasiticides Market Coverage

Report Attribute Key Statistics
Market Revenue in 2025 USD 13.63 Billion
Market Revenue by 2033 USD 20.67 Billion
CAGR from 2025 to 2033 5.34%
Quantitative Units Revenue in USD million/billion, Volume in units
Largest Market North America
Base Year 2024
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Recent Development

  • In July 2025, Merck Animal Health announced that it received U.S. FDA approval for BRAVECTO QUANTUM, a new, once-yearly1 injectable product to treat and protect dogs from fleas and ticks. The product is expected to be available at veterinary clinics and hospitals nationwide by August 2025. (Source- https://www.merck.com)

Veterinary Parasiticides Market Key Players

  • Zoetis Inc.
  • Boehringer Ingelheim Animal Health
  • Elanco Animal Health
  • Merck Animal Health (MSD Animal Health)
  • Norbrook Laboratories
  • Ceva Santé Animale
  • Dechra Pharmaceuticals
  • Vetoquinol
  • Virbac
  • Chanelle Pharma
  • Phibro Animal Health
  • Bimeda Animal Health
  • Huvepharma
  • Zydus Animal Health
  • Ourofino Saúde Animal
  • Ashish Life Science
  • KRKA
  • Kyoritsu Seiyaku
  • Indian Immunologicals
  • Neogen Corporation

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6422

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com|+1 804 441 9344

Related Reports